☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
fibrotic diseases
Bayer Collaborates with Recursion to Fortify Digital Drug Discovery for Fibrotic Diseases
September 10, 2020
AbbVie Exercises its Option to License Morphosys' αvβ6 Integrin Inhibitor Program for Fibrotic Disease
August 25, 2020
Innovent Signs a Clinical Trial Agreement with Sirnaomics to Treat Cancer and Fibrotic Diseases in the US
January 8, 2020
Novartis Collaborates with Pliant Therapeutics to Develop Therapies for NASH and Fibrotic Diseases
October 24, 2019
Chiesi Farmaceutici Licenses Tum Bio's NCE401 for $74M
January 14, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.